iressa
astrazeneca ab - gefitinib - carcinom, ikke-småcellet lunge - antineoplastiske midler - iressa er indiceret til behandling af voksne patienter med lokalt fremskreden eller metastatisk ikke-small-cell lung cancer med aktiverende mutationer af epidermal-growth-factor-receptor tyrosin kinase.
gefitinib "stada" 250 mg filmovertrukne tabletter
stada arzneimittel ag - gefitinib - filmovertrukne tabletter - 250 mg
gefitinib "teva" 250 mg filmovertrukne tabletter
teva b.v. - gefitinib - filmovertrukne tabletter - 250 mg
gefitinib "accord" 250 mg filmovertrukne tabletter
accord healthcare b.v. - gefitinib - filmovertrukne tabletter - 250 mg
sutent
pfizer limited - sunitinib - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - antineoplastiske midler - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
digoxin "dak" 250 mikrogram tabletter
orifarm healthcare a/s - digoxin - tabletter - 250 mikrogram
digoxin "dak" 62,5 mikrogram tabletter
orifarm healthcare a/s - digoxin - tabletter - 62,5 mikrogram
primidon "orifarm" 250 mg tabletter
orifarm generics a/s - primidonum - tabletter - 250 mg
primidon "orifarm" 50 mg tabletter
orifarm generics a/s - primidonum - tabletter - 50 mg
tegretal retard 400 mg depottabletter
europharma.dk aps - carbamazepin - depottabletter - 400 mg